Anderson, CS, Huang, Y, Lindley, RI, Chen, X, Arima, H, Chen, G, Li, Q, Billot, L, Delcourt, C, Bath, PM, Broderick, JP, Demchuk, AM, Donnan, GA, Durham, AC, Lavados, PM, Lee, T-H, Levi, C, Martins, SO, Olavarria, VV, Pandian, JD, Parsons, MW, Pontes-Neto, OM, Ricci, S, Sato, S, Sharma, VK, Silva, F, Song, L, Thang, NH, Wardlaw, JM, Wang, J-G, Wang, X, Woodward, M, Chalmers, J, Robinson, TG, Anderson, CS, Huang, Y, Lindley, RI, Chen, X, Arima, H, Chen, G, Li, Q, Billot, L, Delcourt, C, Bath, PM, Broderick, JP, Demchuk, AM, Donnan, GA, Durham, AC, Lavados, PM, Lee, T-H, Levi, C, Martins, SO, Olavarria, VV, Pandian, JD, Parsons, MW, Pontes-Neto, OM, Ricci, S, Sato, S, Sharma, VK, Silva, F, Song, L, Thang, NH, Wardlaw, JM, Wang, J-G, Wang, X, Woodward, M, Chalmers, J, Robinson, TG, Kim, JS, Stapf, C, Simes, RJ, Hankey, GJ, Sandercock, P, Bousser, MG, Wong, KSL, Scaria, A, Hirakawa, Y, Moullaali, TJ, Carcel, C, Gordon, P, Fuentes-Patarroyo, SX, Benito, D, Chen, R, Cao, Y, Kunchok, A, Winters, S, Coutts, S, Yoshimura, S, You, S, Yang, J, Wu, G, Zhang, S, Manning, L, Mistri, A & Haun 2019, '
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial',
The Lancet, vol. 393, no. 10174, pp. 877-888.
https://doi.org/10.1016/s0140-6736(19)30038-8